Stockscreener 앱 받기
23.00
1.05%
0.24
시간 외 거래:
23.00
전일 마감가:
$22.76
열려 있는:
$22.85
하루 거래량:
17,518
Relative Volume:
0.53
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.74%
1개월 성능:
-4.49%
6개월 성능:
+0.59%
1년 성능:
-0.26%
1일 변동 폭
$22.80
$23.12
1주일 범위
$22.39
$23.12
52주 변동 폭
$21.53
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
명칭
Ishares Genomics Immunology And Healthcare Etf
전화
-
주소
-
IDNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
23.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.06 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
591.95 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
594.61 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
243.49 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
518.58 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf 주식(IDNA)의 최신 뉴스
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for December 2024 - Wealth Awesome
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Quotes, Forecast and News Summary - Benzinga
iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1114 - MSN
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
IDNA ETF: Healthcare Dashboard For February - Seeking Alpha
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Canada Finance
Has Biotechnology Bottomed Out? - Master Investor
2024 Market Forecast: 3 Key Trends in the Healthcare Industry - InvestorPlace
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA: Continues To Underperform, But With Long-Term Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - InvestorPlace
Noticeable performance for Healthcare and Biotech ETFs - Trackinsight
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
RBC iShares Opens the Market - Canada NewsWire
Biotech Shares Too Risky? Here's An ETF For Safely Avoiding The Volatility - Investing.com India
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Lists Cybersecurity and Genomics ETFs - ETF Trends
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
ARK Genomic Revolution ETF - ETFdb.com
Ishares Genomics Immunology And Healthcare Etf (IDNA) 재무 분석
Ishares Genomics Immunology And Healthcare Etf (IDNA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.77%
자본화:
|
볼륨(24시간):